Nilotinib-Induced Elephantine Psoriasis In a Patient With Chronic Myeloid Leukemia: A Rare Case Report and Literature Review

Tyrosine kinase inhibitors are anticancer drugs that disrupt signal transduction pathways in protein kinases by different mechanisms. This group of pharmacologic agents has significantly improved the outcome of patients with chronic myeloid leukemia. However, their effect is not limited to cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadatmadani, Seyedeh Fatemeh, Malakoutikhah, Zahra, Mohaghegh, Fatemeh, Peikar, Mohammadsaleh, Saboktakin, Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249592/
https://www.ncbi.nlm.nih.gov/pubmed/35789635
http://dx.doi.org/10.1016/j.curtheres.2022.100676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249592/
https://www.ncbi.nlm.nih.gov/pubmed/35789635
http://dx.doi.org/10.1016/j.curtheres.2022.100676

Ejemplares similares